CD56 - Revision history

Mark: myeloma

2021-03-26T22:39:06Z

myeloma

← Older revision		Revision as of 22:39, 26 March 2021
Line 12:		Line 12:
	*[[Extranodal NK/T-cell lymphoma, nasal type]].		*[[Extranodal NK/T-cell lymphoma, nasal type]].
	*[[Hepatosplenic T-cell lymphoma]].		*[[Hepatosplenic T-cell lymphoma]].
			*[[Plasma cell myeloma]]

	===Others===		===Others===

Michael: /* Occasionally positive */

2020-06-01T13:24:29Z

Occasionally positive

← Older revision		Revision as of 13:24, 1 June 2020
Line 19:		Line 19:

	==Occasionally positive==		==Occasionally positive==
	*[[Renal cell carcinoma]] ~18% of cases.<ref name=pmid20462442>{{cite journal \|~~vauthors~~=Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P \|title=Evaluation of neuroendocrine markers in renal cell carcinoma \|journal=Diagn Pathol \|volume=5 \|issue= \|pages=28 \|date=May 2010 \|pmid=20462442 \|pmc=2876076 \|doi=10.1186/1746-1596-5-28 \|url=}}</ref>		*[[Renal cell carcinoma]] ~18% of cases.<ref name=pmid20462442>{{cite journal \|authors=Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P \|title=Evaluation of neuroendocrine markers in renal cell carcinoma \|journal=Diagn Pathol \|volume=5 \|issue= \|pages=28 \|date=May 2010 \|pmid=20462442 \|pmc=2876076 \|doi=10.1186/1746-1596-5-28 \|url=}}</ref>

	==See also==		==See also==

Michael: /* Positive */ +RCC occasionally

2020-06-01T13:24:16Z

Positive: +RCC occasionally

← Older revision		Revision as of 13:24, 1 June 2020
Line 17:		Line 17:
	*[[Solid pseudopapillary tumour‎]].		*[[Solid pseudopapillary tumour‎]].
	*[[Follicular dendritic cell sarcoma]].		*[[Follicular dendritic cell sarcoma]].

			==Occasionally positive==
			*[[Renal cell carcinoma]] ~18% of cases.<ref name=pmid20462442>{{cite journal \|vauthors=Ronkainen H, Soini Y, Vaarala MH, Kauppila S, Hirvikoski P \|title=Evaluation of neuroendocrine markers in renal cell carcinoma \|journal=Diagn Pathol \|volume=5 \|issue= \|pages=28 \|date=May 2010 \|pmid=20462442 \|pmc=2876076 \|doi=10.1186/1746-1596-5-28 \|url=}}</ref>

	==See also==		==See also==

Michael at 17:37, 13 September 2014

2014-09-13T17:37:46Z

← Older revision		Revision as of 17:37, 13 September 2014
Line 1:		Line 1:
	'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation ~~and is considered [[neuroendocrine marker~~]].		'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive [[neuroendocrine marker\|marker of neuroendocrine differentiation]].

	==Positive==		==Positive==

Michael at 17:36, 13 September 2014

2014-09-13T17:36:44Z

← Older revision		Revision as of 17:36, 13 September 2014
Line 1:		Line 1:
	'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of [[neuroendocrine ~~differentiation~~]].		'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation and is considered [[neuroendocrine marker]].

	==Positive==		==Positive==

Michael at 17:35, 13 September 2014

2014-09-13T17:35:55Z

← Older revision		Revision as of 17:35, 13 September 2014
Line 1:		Line 1:
	'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.		'''CD56''' is a commonly available [[immunostain]] that is seen in a number of tumours. It is a sensitive marker of [[neuroendocrine differentiation]].

	==Positive==		==Positive==

Michael at 17:18, 13 September 2014

2014-09-13T17:18:26Z

← Older revision		Revision as of 17:18, 13 September 2014
Line 14:		Line 14:

	===Others===		===Others===
			*[[Rhabdomyosarcoma]].<ref name=pmid18487991>{{Cite journal \| last1 = Bahrami \| first1 = A. \| last2 = Gown \| first2 = AM. \| last3 = Baird \| first3 = GS. \| last4 = Hicks \| first4 = MJ. \| last5 = Folpe \| first5 = AL. \| title = Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. \| journal = Mod Pathol \| volume = 21 \| issue = 7 \| pages = 795-806 \| month = Jul \| year = 2008 \| doi = 10.1038/modpathol.2008.86 \| PMID = 18487991 }}</ref>
	*[[Solid pseudopapillary tumour‎]].		*[[Solid pseudopapillary tumour‎]].
	*[[Follicular dendritic cell sarcoma]].		*[[Follicular dendritic cell sarcoma]].

Michael: /* Others */

2014-09-13T08:34:05Z

Others

← Older revision		Revision as of 08:34, 13 September 2014
Line 7:		Line 7:
	*[[Merkel cell carcinoma]].<ref name=pmid12727026>{{Cite journal \| last1 = Kurokawa \| first1 = M. \| last2 = Nabeshima \| first2 = K. \| last3 = Akiyama \| first3 = Y. \| last4 = Maeda \| first4 = S. \| last5 = Nishida \| first5 = T. \| last6 = Nakayama \| first6 = F. \| last7 = Amano \| first7 = M. \| last8 = Ogata \| first8 = K. \| last9 = Setoyama \| first9 = M. \| title = CD56: a useful marker for diagnosing Merkel cell carcinoma. \| journal = J Dermatol Sci \| volume = 31 \| issue = 3 \| pages = 219-24 \| month = May \| year = 2003 \| doi = \| PMID = 12727026 }}</ref>		*[[Merkel cell carcinoma]].<ref name=pmid12727026>{{Cite journal \| last1 = Kurokawa \| first1 = M. \| last2 = Nabeshima \| first2 = K. \| last3 = Akiyama \| first3 = Y. \| last4 = Maeda \| first4 = S. \| last5 = Nishida \| first5 = T. \| last6 = Nakayama \| first6 = F. \| last7 = Amano \| first7 = M. \| last8 = Ogata \| first8 = K. \| last9 = Setoyama \| first9 = M. \| title = CD56: a useful marker for diagnosing Merkel cell carcinoma. \| journal = J Dermatol Sci \| volume = 31 \| issue = 3 \| pages = 219-24 \| month = May \| year = 2003 \| doi = \| PMID = 12727026 }}</ref>

	===~~Others~~===		===Lymphoid===
	*[[Follicular dendritic cell sarcoma]].
	*[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref>		*[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref>
	*[[Chronic myeloid leukemia]].<ref name=nordiqc/>		*[[Chronic myeloid leukemia]].<ref name=nordiqc/>
	*[[Extranodal NK/T-cell lymphoma, nasal type]].		*[[Extranodal NK/T-cell lymphoma, nasal type]].
	*[[Hepatosplenic T-cell lymphoma]].		*[[Hepatosplenic T-cell lymphoma]].

			===Others===
			*[[Solid pseudopapillary tumour‎]].
			*[[Follicular dendritic cell sarcoma]].

	==See also==		==See also==

Michael: /* Others */

2014-09-13T08:11:40Z

Others

← Older revision		Revision as of 08:11, 13 September 2014
Line 12:		Line 12:
	*[[Chronic myeloid leukemia]].<ref name=nordiqc/>		*[[Chronic myeloid leukemia]].<ref name=nordiqc/>
	*[[Extranodal NK/T-cell lymphoma, nasal type]].		*[[Extranodal NK/T-cell lymphoma, nasal type]].
			*[[Hepatosplenic T-cell lymphoma]].

	==See also==		==See also==

Michael: /* Others */

2014-09-13T08:10:32Z

Others

← Older revision		Revision as of 08:10, 13 September 2014
Line 11:		Line 11:
	*[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref>		*[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref>
	*[[Chronic myeloid leukemia]].<ref name=nordiqc/>		*[[Chronic myeloid leukemia]].<ref name=nordiqc/>
	*[[Extranodal ~~natural kill~~ lymphoma]].		*[[Extranodal NK/T-cell lymphoma, nasal type]].

	==See also==		==See also==
	*[[Immunohistochemistry]].		*[[Immunohistochemistry]].